SCHEMBL6963318

SCHEMBL6963318

N#CCOc1ccc(-c2cc(O)c(SCCc3ccccc3)c(=O)o2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.38
CYP1A2 P05177 2/20 0.38
TNKS O95271 1/20 0.38
ABCB1 P08183 2/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 2/20 0.37
ABCG2 Q9UNQ0 1/20 0.37
BCHE P06276 2/20 0.37
ACHE P22303 2/20 0.37
SLC2A1 P11166 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
FFAR1 O14842 1/20 0.36
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALDH2 P05091 1/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952547 0.87 ABCB1 (0.50) CYP1A1CYP1A2ABCB1MAPTBCHE
SCHEMBL6956331 0.87 SLC16A3 (0.46) ABCB1MAPTBCHEACHEL3MBTL1
SCHEMBL6960907 0.86 ACHE (0.42) ABCB1MAPTBCHEACHEL3MBTL1
SCHEMBL6958378 0.86 MAOA (0.45) ABCB1BCHEACHEFFAR1MAOA
SCHEMBL6956259 0.85 XDH (0.48) ABCB1MAPTHPGDABCG2L3MBTL1
SCHEMBL6957097 0.85 CYSLTR1 (0.41) ABCB1MAPTBCHEACHEL3MBTL1
SCHEMBL6954678 0.84 ABCB1 (0.43) ABCB1MAPTL3MBTL1FFAR1MAOA
SCHEMBL6954657 0.83 SMN1; SMN2 (0.44) CYP1A1CYP1A2ABCB1MAPTHPGD
SCHEMBL6960622 0.83 SMN1; SMN2 (0.49) CYP1A1CYP1A2TNKSABCB1MAPT
SCHEMBL6963439 0.83 SMN1; SMN2 (0.40) CYP1A1CYP1A2ABCB1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed